Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.

This report aims to provide a comprehensive study of the global market for Bioactive Protein and Peptides.
Market Report Coverage

(1) Global Bioactive Protein and Peptides market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Bioactive Protein and Peptides market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Bioactive Protein and Peptides market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Bioactive Protein and Peptides segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Bioactive Protein and Peptides segment by type and by application and regional segment by type and by application.

(6) Bioactive Protein and Peptides industry supply chain, upstream, midstream and downstream analysis.

According to Latest Study, the global market for Bioactive Protein and Peptides should grow from US$ 1695.8 million in 2022 to US$ 2706.1 million by 2029, with a CAGR of 6.9% for the period of 2023-2029..

Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

Overview of the regional outlook of the Market:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by source, covers

Plant Source

Animal Source

Market segment by Application, can be divided into

Functional Food

Dietary Supplements

Personal Care

Animal Nutrition

Other

Market segment by players, this report covers

Gelita

Kerry Group

Vital Proteins

Rousselot

BRF Ingredients

Bunge Ltd

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Hubei Reborn Biotech

Seagarden

Shandong Hengxin Biotech

Baotou Dongbao Bio-Tech

Wuhan Jiushengtang Biotech

Morinaga Milk

Collagile

Nuritas

SmartPEP

1 Market Overview

1.1 Product Overview and Scope of Bioactive Protein and Peptides

1.2 Global Bioactive Protein and Peptides Market Size and Forecast

1.3 China Bioactive Protein and Peptides Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Bioactive Protein and Peptides Share in Global Market, 2018-2029

1.4.2 Bioactive Protein and Peptides Market Size: China VS Global, 2018-2029

1.5 Bioactive Protein and Peptides Market Dynamics

1.5.1 Bioactive Protein and Peptides Market Drivers

1.5.2 Bioactive Protein and Peptides Market Restraints

1.5.3 Bioactive Protein and Peptides Industry Trends

1.5.4 Bioactive Protein and Peptides Industry Policy

2 Global Competitive Situation by Company

2.1 Global Bioactive Protein and Peptides Revenue by Company (2018-2023)

2.2 Global Bioactive Protein and Peptides Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Bioactive Protein and Peptides Concentration Ratio

2.4 Global Bioactive Protein and Peptides Mergers & Acquisitions, Expansion Plans

2.5 Global Bioactive Protein and Peptides Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Bioactive Protein and Peptides Revenue by Company (2018-2023)

3.2 China Bioactive Protein and Peptides Bioactive Protein and Peptides Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Bioactive Protein and Peptides, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Bioactive Protein and Peptides Industry Chain

4.2 Bioactive Protein and Peptides Upstream Analysis

4.3 Bioactive Protein and Peptides Midstream Analysis

4.4 Bioactive Protein and Peptides Downstream Analysis

5 Sights by Source

5.1 Bioactive Protein and Peptides Classification

5.1.1 Plant Source

5.1.2 Animal Source

5.2 By Source, Global Bioactive Protein and Peptides Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Source, Global Bioactive Protein and Peptides Revenue, 2018-2029

6 Sights by Application

6.1 Bioactive Protein and Peptides Segment by Application

6.1.1 Functional Food

6.1.2 Dietary Supplements

6.1.3 Personal Care

6.1.4 Animal Nutrition

6.1.5 Other

6.2 By Application, Global Bioactive Protein and Peptides Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Bioactive Protein and Peptides Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Bioactive Protein and Peptides Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Bioactive Protein and Peptides Market Size, 2018-2029

7.3 North America

7.3.1 North America Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Bioactive Protein and Peptides Market Size Market Share

7.4 Europe

7.4.1 Europe Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Bioactive Protein and Peptides Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Bioactive Protein and Peptides Market Size Market Share

7.6 South America

7.6.1 South America Bioactive Protein and Peptides Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Bioactive Protein and Peptides Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Bioactive Protein and Peptides Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Bioactive Protein and Peptides Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Bioactive Protein and Peptides Market Size, 2018-2029

8.3.2 By Company, U.S. Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.3.3 By Source, U.S. Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Bioactive Protein and Peptides Market Size, 2018-2029

8.4.2 By Company, Europe Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.4.3 By Source, Europe Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Bioactive Protein and Peptides Market Size, 2018-2029

8.5.2 By Company, China Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.5.3 By Source, China Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Bioactive Protein and Peptides Market Size, 2018-2029

8.6.2 By Company, Japan Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.6.3 By Source, Japan Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Bioactive Protein and Peptides Market Size, 2018-2029

8.7.2 By Company, South Korea Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.7.3 By Source, South Korea Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Bioactive Protein and Peptides Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.8.3 By Source, Southeast Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Bioactive Protein and Peptides Market Size, 2018-2029

8.9.2 By Company, India Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.9.3 By Source, India Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Bioactive Protein and Peptides Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Bioactive Protein and Peptides Revenue Market Share, 2018-2023

8.10.3 By Source, Middle East & Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Gelita

9.1.1 Gelita Company Information, Head Office, Market Area and Industry Position

9.1.2 Gelita Company Profile and Main Business

9.1.3 Gelita Bioactive Protein and Peptides Models, Specifications and Application

9.1.4 Gelita Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.1.5 Gelita Recent Developments

9.2 Kerry Group

9.2.1 Kerry Group Company Information, Head Office, Market Area and Industry Position

9.2.2 Kerry Group Company Profile and Main Business

9.2.3 Kerry Group Bioactive Protein and Peptides Models, Specifications and Application

9.2.4 Kerry Group Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.2.5 Kerry Group Recent Developments

9.3 Vital Proteins

9.3.1 Vital Proteins Company Information, Head Office, Market Area and Industry Position

9.3.2 Vital Proteins Company Profile and Main Business

9.3.3 Vital Proteins Bioactive Protein and Peptides Models, Specifications and Application

9.3.4 Vital Proteins Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.3.5 Vital Proteins Recent Developments

9.4 Rousselot

9.4.1 Rousselot Company Information, Head Office, Market Area and Industry Position

9.4.2 Rousselot Company Profile and Main Business

9.4.3 Rousselot Bioactive Protein and Peptides Models, Specifications and Application

9.4.4 Rousselot Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.4.5 Rousselot Recent Developments

9.5 BRF Ingredients

9.5.1 BRF Ingredients Company Information, Head Office, Market Area and Industry Position

9.5.2 BRF Ingredients Company Profile and Main Business

9.5.3 BRF Ingredients Bioactive Protein and Peptides Models, Specifications and Application

9.5.4 BRF Ingredients Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.5.5 BRF Ingredients Recent Developments

9.6 Bunge Ltd

9.6.1 Bunge Ltd Company Information, Head Office, Market Area and Industry Position

9.6.2 Bunge Ltd Company Profile and Main Business

9.6.3 Bunge Ltd Bioactive Protein and Peptides Models, Specifications and Application

9.6.4 Bunge Ltd Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.6.5 Bunge Ltd Recent Developments

9.7 Ingredia Nutritional

9.7.1 Ingredia Nutritional Company Information, Head Office, Market Area and Industry Position

9.7.2 Ingredia Nutritional Company Profile and Main Business

9.7.3 Ingredia Nutritional Bioactive Protein and Peptides Models, Specifications and Application

9.7.4 Ingredia Nutritional Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.7.5 Ingredia Nutritional Recent Developments

9.8 Gelatines Weishardt

9.8.1 Gelatines Weishardt Company Information, Head Office, Market Area and Industry Position

9.8.2 Gelatines Weishardt Company Profile and Main Business

9.8.3 Gelatines Weishardt Bioactive Protein and Peptides Models, Specifications and Application

9.8.4 Gelatines Weishardt Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.8.5 Gelatines Weishardt Recent Developments

9.9 PanTheryx

9.9.1 PanTheryx Company Information, Head Office, Market Area and Industry Position

9.9.2 PanTheryx Company Profile and Main Business

9.9.3 PanTheryx Bioactive Protein and Peptides Models, Specifications and Application

9.9.4 PanTheryx Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.9.5 PanTheryx Recent Developments

9.10 Hubei Reborn Biotech

9.10.1 Hubei Reborn Biotech Company Information, Head Office, Market Area and Industry Position

9.10.2 Hubei Reborn Biotech Company Profile and Main Business

9.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Models, Specifications and Application

9.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.10.5 Hubei Reborn Biotech Recent Developments

9.11 Seagarden

9.11.1 Seagarden Company Information, Head Office, Market Area and Industry Position

9.11.2 Seagarden Company Profile and Main Business

9.11.3 Seagarden Bioactive Protein and Peptides Models, Specifications and Application

9.11.4 Seagarden Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.11.5 Seagarden Recent Developments

9.12 Shandong Hengxin Biotech

9.12.1 Shandong Hengxin Biotech Company Information, Head Office, Market Area and Industry Position

9.12.2 Shandong Hengxin Biotech Company Profile and Main Business

9.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Models, Specifications and Application

9.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.12.5 Shandong Hengxin Biotech Recent Developments

9.13 Baotou Dongbao Bio-Tech

9.13.1 Baotou Dongbao Bio-Tech Company Information, Head Office, Market Area and Industry Position

9.13.2 Baotou Dongbao Bio-Tech Company Profile and Main Business

9.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Models, Specifications and Application

9.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.13.5 Baotou Dongbao Bio-Tech Recent Developments

9.14 Wuhan Jiushengtang Biotech

9.14.1 Wuhan Jiushengtang Biotech Company Information, Head Office, Market Area and Industry Position

9.14.2 Wuhan Jiushengtang Biotech Company Profile and Main Business

9.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Models, Specifications and Application

9.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.14.5 Wuhan Jiushengtang Biotech Recent Developments

9.15 Morinaga Milk

9.15.1 Morinaga Milk Company Information, Head Office, Market Area and Industry Position

9.15.2 Morinaga Milk Company Profile and Main Business

9.15.3 Morinaga Milk Bioactive Protein and Peptides Models, Specifications and Application

9.15.4 Morinaga Milk Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.15.5 Morinaga Milk Recent Developments

9.16 Collagile

9.16.1 Collagile Company Information, Head Office, Market Area and Industry Position

9.16.2 Collagile Company Profile and Main Business

9.16.3 Collagile Bioactive Protein and Peptides Models, Specifications and Application

9.16.4 Collagile Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.16.5 Collagile Recent Developments

9.17 Nuritas

9.17.1 Nuritas Company Information, Head Office, Market Area and Industry Position

9.17.2 Nuritas Company Profile and Main Business

9.17.3 Nuritas Bioactive Protein and Peptides Models, Specifications and Application

9.17.4 Nuritas Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.17.5 Nuritas Recent Developments

9.18 SmartPEP

9.18.1 SmartPEP Company Information, Head Office, Market Area and Industry Position

9.18.2 SmartPEP Company Profile and Main Business

9.18.3 SmartPEP Bioactive Protein and Peptides Models, Specifications and Application

9.18.4 SmartPEP Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

9.18.5 SmartPEP Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Bioactive Protein and Peptides Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Bioactive Protein and Peptides Market Restraints

Table 3. Bioactive Protein and Peptides Market Trends

Table 4. Bioactive Protein and Peptides Industry Policy

Table 5. Global Bioactive Protein and Peptides Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Bioactive Protein and Peptides Revenue Market Share by Company (2018-2023)

Table 7. Global Bioactive Protein and Peptides Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Bioactive Protein and Peptides Mergers & Acquisitions, Expansion Plans

Table 9. Global Bioactive Protein and Peptides Manufacturers Product Type

Table 10. China Bioactive Protein and Peptides Revenue by Company (2018-2023) & (US$ million)

Table 11. China Bioactive Protein and Peptides Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Bioactive Protein and Peptides Upstream (Raw Materials)

Table 13. Global Bioactive Protein and Peptides Typical Customers

Table 14. Bioactive Protein and Peptides Typical Distributors

Table 15. By Source, Global Bioactive Protein and Peptides Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Bioactive Protein and Peptides Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Bioactive Protein and Peptides Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Bioactive Protein and Peptides Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Bioactive Protein and Peptides Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Bioactive Protein and Peptides Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Bioactive Protein and Peptides Revenue Market Share, 2018-2029

Table 22. Gelita Company Information, Head Office, Market Area and Industry Position

Table 23. Gelita Company Profile and Main Business

Table 24. Gelita Bioactive Protein and Peptides Models, Specifications and Application

Table 25. Gelita Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 26. Gelita Recent Developments

Table 27. Kerry Group Company Information, Head Office, Market Area and Industry Position

Table 28. Kerry Group Company Profile and Main Business

Table 29. Kerry Group Bioactive Protein and Peptides Models, Specifications and Application

Table 30. Kerry Group Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 31. Kerry Group Recent Developments

Table 32. Vital Proteins Company Information, Head Office, Market Area and Industry Position

Table 33. Vital Proteins Company Profile and Main Business

Table 34. Vital Proteins Bioactive Protein and Peptides Models, Specifications and Application

Table 35. Vital Proteins Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 36. Vital Proteins Recent Developments

Table 37. Rousselot Company Information, Head Office, Market Area and Industry Position

Table 38. Rousselot Company Profile and Main Business

Table 39. Rousselot Bioactive Protein and Peptides Models, Specifications and Application

Table 40. Rousselot Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 41. Rousselot Recent Developments

Table 42. BRF Ingredients Company Information, Head Office, Market Area and Industry Position

Table 43. BRF Ingredients Company Profile and Main Business

Table 44. BRF Ingredients Bioactive Protein and Peptides Models, Specifications and Application

Table 45. BRF Ingredients Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 46. BRF Ingredients Recent Developments

Table 47. Bunge Ltd Company Information, Head Office, Market Area and Industry Position

Table 48. Bunge Ltd Company Profile and Main Business

Table 49. Bunge Ltd Bioactive Protein and Peptides Models, Specifications and Application

Table 50. Bunge Ltd Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 51. Bunge Ltd Recent Developments

Table 52. Ingredia Nutritional Company Information, Head Office, Market Area and Industry Position

Table 53. Ingredia Nutritional Company Profile and Main Business

Table 54. Ingredia Nutritional Bioactive Protein and Peptides Models, Specifications and Application

Table 55. Ingredia Nutritional Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 56. Ingredia Nutritional Recent Developments

Table 57. Gelatines Weishardt Company Information, Head Office, Market Area and Industry Position

Table 58. Gelatines Weishardt Company Profile and Main Business

Table 59. Gelatines Weishardt Bioactive Protein and Peptides Models, Specifications and Application

Table 60. Gelatines Weishardt Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 61. Gelatines Weishardt Recent Developments

Table 62. PanTheryx Company Information, Head Office, Market Area and Industry Position

Table 63. PanTheryx Company Profile and Main Business

Table 64. PanTheryx Bioactive Protein and Peptides Models, Specifications and Application

Table 65. PanTheryx Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 66. PanTheryx Recent Developments

Table 67. Hubei Reborn Biotech Company Information, Head Office, Market Area and Industry Position

Table 68. Hubei Reborn Biotech Company Profile and Main Business

Table 69. Hubei Reborn Biotech Bioactive Protein and Peptides Models, Specifications and Application

Table 70. Hubei Reborn Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 71. Hubei Reborn Biotech Recent Developments

Table 72. Seagarden Company Information, Head Office, Market Area and Industry Position

Table 73. Seagarden Company Profile and Main Business

Table 74. Seagarden Bioactive Protein and Peptides Models, Specifications and Application

Table 75. Seagarden Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 76. Seagarden Recent Developments

Table 77. Shandong Hengxin Biotech Company Information, Head Office, Market Area and Industry Position

Table 78. Shandong Hengxin Biotech Company Profile and Main Business

Table 79. Shandong Hengxin Biotech Bioactive Protein and Peptides Models, Specifications and Application

Table 80. Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 81. Shandong Hengxin Biotech Recent Developments

Table 82. Baotou Dongbao Bio-Tech Company Information, Head Office, Market Area and Industry Position

Table 83. Baotou Dongbao Bio-Tech Company Profile and Main Business

Table 84. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Models, Specifications and Application

Table 85. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 86. Baotou Dongbao Bio-Tech Recent Developments

Table 87. Wuhan Jiushengtang Biotech Company Information, Head Office, Market Area and Industry Position

Table 88. Wuhan Jiushengtang Biotech Company Profile and Main Business

Table 89. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Models, Specifications and Application

Table 90. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 91. Wuhan Jiushengtang Biotech Recent Developments

Table 92. Morinaga Milk Company Information, Head Office, Market Area and Industry Position

Table 93. Morinaga Milk Company Profile and Main Business

Table 94. Morinaga Milk Bioactive Protein and Peptides Models, Specifications and Application

Table 95. Morinaga Milk Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 96. Morinaga Milk Recent Developments

Table 97. Collagile Company Information, Head Office, Market Area and Industry Position

Table 98. Collagile Company Profile and Main Business

Table 99. Collagile Bioactive Protein and Peptides Models, Specifications and Application

Table 100. Collagile Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 101. Collagile Recent Developments

Table 102. Nuritas Company Information, Head Office, Market Area and Industry Position

Table 103. Nuritas Company Profile and Main Business

Table 104. Nuritas Bioactive Protein and Peptides Models, Specifications and Application

Table 105. Nuritas Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 106. Nuritas Recent Developments

Table 107. SmartPEP Company Information, Head Office, Market Area and Industry Position

Table 108. SmartPEP Company Profile and Main Business

Table 109. SmartPEP Bioactive Protein and Peptides Models, Specifications and Application

Table 110. SmartPEP Bioactive Protein and Peptides Revenue and Gross Margin, 2018-2023

Table 111. SmartPEP Recent Developments

List of Figure

Figure 1. Bioactive Protein and Peptides Picture

Figure 2. Global Bioactive Protein and Peptides Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Bioactive Protein and Peptides Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Bioactive Protein and Peptides Market Share of Global

Figure 5. Global Bioactive Protein and Peptides Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Bioactive Protein and Peptides Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Bioactive Protein and Peptides Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Bioactive Protein and Peptides Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Bioactive Protein and Peptides Industry Chain

Figure 10. Plant Source

Figure 11. Animal Source

Figure 12. By Source, Global Bioactive Protein and Peptides Revenue, 2018-2029, US$ Million

Figure 13. By Source, Global Bioactive Protein and Peptides Revenue Market Share, 2018-2029

Figure 14. Functional Food

Figure 15. Dietary Supplements

Figure 16. Personal Care

Figure 17. Animal Nutrition

Figure 18. Other

Figure 19. By Application, Global Bioactive Protein and Peptides Revenue, 2018-2029, US$ Million

Figure 20. By Application, Global Bioactive Protein and Peptides Revenue Market Share, 2018-2029

Figure 21. By Region, Global Bioactive Protein and Peptides Revenue Market Share, 2018-2029

Figure 22. North America Bioactive Protein and Peptides Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, North America Bioactive Protein and Peptides Revenue Market Share, 2018-2023

Figure 24. Europe Bioactive Protein and Peptides Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, Europe Bioactive Protein and Peptides Revenue Market Share, 2018-2023

Figure 26. Asia Pacific Bioactive Protein and Peptides Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country/Region, Asia Pacific Bioactive Protein and Peptides Revenue Market Share, 2018-2023

Figure 28. South America Bioactive Protein and Peptides Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country, South America Bioactive Protein and Peptides Revenue Market Share, 2018-2023

Figure 30. Middle East & Africa Bioactive Protein and Peptides Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. U.S. Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 32. By Company, U.S. Bioactive Protein and Peptides Market Share, 2018-2023

Figure 33. By Source, U.S. Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 34. By Application, U.S. Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 35. Europe Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 36. By Company, Europe Bioactive Protein and Peptides Market Share, 2018-2023

Figure 37. By Source, Europe Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 38. By Application, Europe Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 39. China Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 40. By Company, China Bioactive Protein and Peptides Market Share, 2018-2023

Figure 41. By Source, China Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 42. By Application, China Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 43. Japan Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 44. By Company, Japan Bioactive Protein and Peptides Market Share, 2018-2023

Figure 45. By Source, Japan Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 46. By Application, Japan Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 47. South Korea Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 48. By Company, South Korea Bioactive Protein and Peptides Market Share, 2018-2023

Figure 49. By Source, South Korea Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 50. By Application, South Korea Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 51. Southeast Asia Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 52. By Company, Southeast Asia Bioactive Protein and Peptides Market Share, 2018-2023

Figure 53. By Source, Southeast Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 54. By Application, Southeast Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 55. India Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 56. By Company, India Bioactive Protein and Peptides Market Share, 2018-2023

Figure 57. By Source, India Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 58. By Application, India Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 59. Middle East & Asia Bioactive Protein and Peptides Revenue, 2018-2029, (US$ Million)

Figure 60. By Company, Middle East & Asia Bioactive Protein and Peptides Market Share, 2018-2023

Figure 61. By Source, Middle East & Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 62. By Application, Middle East & Asia Bioactive Protein and Peptides Revenue Market Share, 2022 VS 2029

Figure 63. Research Methodology

Figure 64. Breakdown of Primary Interviews

Figure 65. Bottom-up Approaches

Figure 66. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)